drugset / Trial / NCT00490828

Influence of Hydrocortisone on Immunologic Markers and Health Care Related Quality of Life in Patients After Cardiac Surgery

NCT00490828

Phase 4 Completed 120 enrolled Ludwig-Maximilians - University of Munich
RandomizedParallel-groupDouble-blindPrevention

Summary

Hydrocortisone has been shown to improve the early outcome of high risk patients after cardiac surgery. A potential mechanism resulting in this effect may be its immunomodulatory action. In this prospective interventional study this hypothesis is to be proven.

Timeline

Start
2007-06
Primary completion
2008-05
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified